Malignant hyperthermia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000768:Anesthesia, General / Q000009:adverse effects; D000769:Anesthesia, Inhalation / Q000009:adverse effects; D001639:Bicarbonates / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D017679:Cryotherapy; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000139:chemically induced* / Q000150:complications / Q000235:genetics / Q000628:therapy; D008661:Metabolism, Inborn Errors / Q000150:complications; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000009:adverse effects; D012121:Respiration, Artificial; D014882:Water-Electrolyte Balance
D001639:Bicarbonates; D009125:Muscle Relaxants, Central